Phio Pharmaceuticals to present PH-762 clinical update at Life Sciences Future Conference
P
PHIO• Conference presentation on PH-762
Phio Pharmaceuticals will present at the Life Sciences Future 2026 Conference on September 30 to October 1, 2026.
Management plans a clinical development update on PH-762 following its completed Phase 1b study in cutaneous squamous cell carcinoma.
The talk is scheduled for September 30, 2026 at 10:20 a.m. ET in King of Prussia, Pennsylvania.
